INS and type 2 diabetes mellitus: To investigate the effects of combining oral hypoglycemic agents with short‐term intensive insulin therapy (SIIT) via continuous subcutaneous insulin infusion (CSII) on glycemic outcomes in adults with newly diagnosed type 2 diabetes mellitus.